Chembio Historical Balance Sheet

CEMI
 Stock
  

USD 0.86  0.01  1.18%   

Trend analysis of Chembio Diagnostics balance sheet accounts such as Receivables of 12.3 M, Accounts Payable of 8.4 M or Total Assets of 58.3 M provides information on Chembio Diagnostics' total assets, liabilities, and equity, which is the actual value of Chembio Diagnostics to its prevalent stockholders. By breaking down trends over time using Chembio Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Chembio Diagnostics prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chembio Diagnostics is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Chembio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Chembio Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Chembio Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chembio Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chembio currently owns. An asset can also be divided into two categories, current and non-current.

Chembio Diagnostics Balance Sheet Chart

Chembio Diagnostics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Chembio Diagnostics uses and utilizes its capital. It also shows what exactly a company owns and owes.
Chembio Diagnostics Accounts Payable is most likely to increase significantly in the upcoming years. The last year's value of Accounts Payable was reported at 7.75 Million. The current Current Assets is estimated to increase to about 59.6 M, while Accumulated Other Comprehensive Income is projected to decrease to (608 K).

Total Assets

Total assets refers to the total amount of Chembio Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chembio Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; [Investments]; Goodwill and Intangible Assets; Property Plant and Equipment Net; Tax Assets and Trade and Non Trade Receivables.

Current Assets

Current assets of Chembio Diagnostics include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Chembio Diagnostics. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Chembio Diagnostics balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Chembio Diagnostics books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Chembio Diagnostics balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Chembio Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chembio Diagnostics Accounts Payable is most likely to increase significantly in the upcoming years. The last year's value of Accounts Payable was reported at 7.75 Million. The current Current Assets is estimated to increase to about 59.6 M, while Accumulated Other Comprehensive Income is projected to decrease to (608 K).
 2019 2020 2021 2022 (projected)
Receivables3.66 M3.38 M11.44 M12.34 M
Inventories9.6 M12.52 M12.92 M13.94 M

Chembio Diagnostics balance sheet Correlations

0.610.950.970.960.860.960.930.860.920.83-0.710.870.660.980.960.940.90.930.950.630.69
0.610.780.590.770.290.660.490.790.460.7-0.850.710.020.520.570.770.390.80.531.00.28
0.950.780.910.980.710.960.870.940.850.94-0.860.850.430.90.920.990.80.990.90.790.61
0.970.590.910.940.90.940.930.820.930.79-0.650.890.660.980.950.910.940.90.950.60.62
0.960.770.980.940.740.990.890.940.880.89-0.840.880.490.910.940.980.840.980.920.780.62
0.860.290.710.90.740.770.90.590.910.59-0.350.710.780.910.880.720.940.70.90.30.51
0.960.660.960.940.990.770.920.910.910.87-0.790.860.540.920.950.950.880.950.940.670.65
0.930.490.870.930.890.90.920.841.00.77-0.660.690.580.910.990.880.980.860.990.50.6
0.860.790.940.820.940.590.910.840.830.87-0.960.720.240.780.880.930.760.940.850.80.63
0.920.460.850.930.880.910.911.00.830.76-0.640.680.60.910.990.860.990.850.990.470.6
0.830.70.940.790.890.590.870.770.870.76-0.830.710.230.780.840.950.70.950.810.70.54
-0.71-0.85-0.86-0.65-0.84-0.35-0.79-0.66-0.96-0.64-0.83-0.610.0-0.61-0.72-0.85-0.55-0.87-0.68-0.85-0.55
0.870.710.850.890.880.710.860.690.720.680.71-0.610.610.870.750.830.680.830.740.720.54
0.660.020.430.660.490.780.540.580.240.60.230.00.610.720.570.410.640.380.590.040.51
0.980.520.90.980.910.910.920.910.780.910.78-0.610.870.720.940.890.920.880.940.540.69
0.960.570.920.950.940.880.950.990.880.990.84-0.720.750.570.940.930.970.921.00.580.61
0.940.770.990.910.980.720.950.880.930.860.95-0.850.830.410.890.930.811.00.910.780.58
0.90.390.80.940.840.940.880.980.760.990.7-0.550.680.640.920.970.810.790.970.40.59
0.930.80.990.90.980.70.950.860.940.850.95-0.870.830.380.880.921.00.790.890.80.56
0.950.530.90.950.920.90.940.990.850.990.81-0.680.740.590.941.00.910.970.890.540.61
0.631.00.790.60.780.30.670.50.80.470.7-0.850.720.040.540.580.780.40.80.540.28
0.690.280.610.620.620.510.650.60.630.60.54-0.550.540.510.690.610.580.590.560.610.28
Click cells to compare fundamentals

Chembio Diagnostics Account Relationship Matchups

Chembio Diagnostics balance sheet Accounts

201720182019202020212022 (projected)
Inventories4.42 M7.85 M9.6 M12.52 M12.92 M13.94 M
Receivables2.09 M7.37 M3.66 M3.38 M11.44 M12.34 M
Accounts Payable1.49 M3.62 M3.14 M5.73 M7.75 M8.36 M
Total Assets16.62 M40.91 M55.73 M64.89 M73.25 M58.3 M
Current Assets10.85 M28.45 M32.22 M39.74 M55.23 M59.59 M
Assets Non Current5.76 M12.46 M23.51 M25.15 M18.02 M15.89 M
Cash and Equivalents3.79 M12.52 M18.27 M23.07 M28.77 M31.04 M
Cash and Equivalents USD3.79 M12.52 M18.27 M23.07 M28.77 M31.04 M
Deferred Revenue50 K422.9 K125 K1.61 M1.85 M1.99 M
Shareholders Equity13.08 M33.33 M24.04 M27.78 M34.26 M30.33 M
Shareholders Equity USD13.08 M33.33 M24.04 M27.78 M34.26 M30.33 M
Inventory4.42 M7.85 M9.6 M12.52 M12.92 M10.27 M
Total Liabilities3.54 M7.58 M31.69 M37.12 M38.99 M42.07 M
Current Liabilities3.1 M6.52 M6.44 M12.35 M15.28 M16.49 M
Trade and Non Trade Payables3.05 M5.89 M5.53 M10.04 M13.13 M14.16 M
Property Plant and Equipment Net1.91 M2.87 M13.17 M15.03 M14.64 M15.8 M
Trade and Non Trade Receivables2.09 M7.37 M3.66 M3.38 M11.44 M12.34 M
Accumulated Retained Earnings Deficit(50.04 M)(57.91 M)(71.59 M)(97.11 M)(131.01 M)(134.46 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chembio Diagnostics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Chembio Diagnostics

0.71AXDXAccelerate Diagnosti Earnings Call  This WeekPairCorr

Moving against Chembio Diagnostics

0.58ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
0.58ABVCAbvc Biopharma Earnings Call  This WeekPairCorr
0.57LMDXLumiradx Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
26.8 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.